ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,745 | -46.8% | 16,915 | -33.7% | 0.00% | – |
| Q2 2023 | $95,370 | -69.7% | 25,500 | -72.9% | 0.00% | – |
| Q1 2023 | $315,228 | -31.4% | 94,098 | -1.5% | 0.00% | -100.0% |
| Q4 2022 | $459,663 | -14.6% | 95,564 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $538,000 | -22.3% | 94,592 | -3.0% | 0.00% | 0.0% |
| Q2 2022 | $692,000 | +128.4% | 97,524 | +132.3% | 0.00% | – |
| Q1 2022 | $303,000 | -31.0% | 41,985 | -14.5% | 0.00% | -100.0% |
| Q4 2021 | $439,000 | -74.2% | 49,115 | +1.3% | 0.00% | -50.0% |
| Q3 2021 | $1,699,000 | -11.1% | 48,466 | -45.5% | 0.00% | 0.0% |
| Q2 2021 | $1,912,000 | +40.6% | 89,007 | +304.1% | 0.00% | 0.0% |
| Q1 2021 | $1,360,000 | +48.5% | 22,025 | +0.4% | 0.00% | +100.0% |
| Q4 2020 | $916,000 | – | 21,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |